Urocortin-2 in Acute Heart Failure: Role as a Marker of Volume Overload and Pulmonary Hypertension
Autores da FMUP
Participantes de fora da FMUP
- Maia Rocha, C
- Adao, R
- Bettencourt, P
Unidades de investigação
Abstract
Urocortin (Ucn)-2 has shown promising therapeutic effects on heart failure (HF). However, there are still significant knowledge gaps regarding the role and modulation of the endogenous Ucn-2 axis in the cardiovascular system and, specifically, in acute HF. We evaluated Ucn-2 levels in admission serum samples of 80 acute HF patients and assessed their association with clinical, analytical and echocardiographic parameters. Median age was 76.5 years, and 37 patients (46%) were male. Median serum Ucn-2 was 2.3ng/mL. Ucn-2 levels were positively associated with peripheral edemas (P = 0.022), hepatomegaly (P = 0.007) and sodium retention score (r = 0.37, P = 0.001) and inversely correlated with inferior vena cava collapse at inspiration (r = -0.37, P = 0.001). Additionally, patients with higher Ucn-2 levels had a higher prevalence of right atrial dilation (P = 0.027), right ventricle dilation (P = 0.008), and higher systolic pulmonary artery pressure (r = 0.34, P = 0.002). Regarding analytical parameters, Ucn-2 correlated positively with log BNP (r = 0.22, P = 0.055) and inversely with uric acid (r = 0.24, P = 0.029) and total (r = -0.30, P = 0.007) and low-density lipoprotein cholesterol (r = -0.23, P = 0.038). No associations were found between Ucn-2 and age, sex or left heart structure or function. In conclusion, Circulating Ucn-2 was associated with clinical and echocardiographic markers of volume overload and pulmonary hypertension in acute HF patients.
Copyright © 2021 Elsevier Inc. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 0146-2806, 1535-6280
- Tipo:
- Review
- Páginas:
- 100860-100860
- Link para outro recurso:
- www.scopus.com
Current Problems in Cardiology Mosby Inc.
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Aged; Biomarkers; Echocardiography; Heart Failure; Humans; Hypertension, Pulmonary; Male; Urocortins; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; brain natriuretic peptide; dipeptidyl carboxypeptidase inhibitor; loop diuretic agent; low density lipoprotein cholesterol; spironolactone; uric acid; urocortin II; biological marker; urocortin; acute heart failure; age; aged; cardiac patient; cardiovascular parameters; clinical feature; controlled study; disease association; disease marker; echocardiography; enzyme linked immunosorbent assay; female; gender; heart atrium enlargement; heart failure; heart left atrium; heart left ventricle; heart left ventricle function; heart right atrium; heart right ventricle; hepatomegaly; human; hypervolemia; inferior cava vein; laboratory test; low density lipoprotein cholesterol level; major clinical study; male; peripheral edema; Portugal; protein blood level; protein function; pulmonary artery systolic pressure; pulmonary
Financiamento
Proyectos asociados
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Bypass) . 2020
FGF23 effects within the vasculature: more insights into Atherosclerosis?
Investigador Principal: Paulo Manuel Barreiros de Castro Chaves
Estudo Clínico Académico (FGF23) . 2020
Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Aortic Valve Replacemen) . 2020
Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis
Investigador Principal: Paulo Manuel Barreiros de Castro Chaves
Estudo Clínico Académico . 2021
Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Early anticoagulation in atrial fibrillation-related acute ischemic stroke: efficacy and safety profile
Investigador Principal: Mariana Marques Santos Pintalhão
Ensaio Clínico Académico (Anticoagulation) . 2021
Persistent Pulmonary Hypertension of the Newborn: Pathophysiological mechanisms and novel therapeutic approaches
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2020
New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Pthological rola of urocortin-2 in pulmonaryn hypertension - therapeutic implications
Investigador Principal: Carmen Dulce da Silveira Brás Silva Ribeiro
Estudo Clínico Académico . 2020
Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Clinical prediction rules in the prognosis of cerebral hemorrhage: Prognostication of mortality and functional recovery
Investigador Principal: Paulo Manuel Barreiros de Castro Chaves
Estudo Clínico Académico . 2020
Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Pintalhao M,Maia C,Castro P,Adao R,Barros A,Martins R,Leite A,Bettencourt P,Bras C. Urocortin-2 in Acute Heart Failure: Role as a Marker of Volume Overload and Pulmonary Hypertension. Curr. Probl. Cardiol. 2022. 47(4):p. 100860-100860. IF:4,200. (2).